EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging

Yun Xu, Qingxuan Wan, Xihui Ren, Yutao Jiang, Fang Wang, Jing Yao, Peng Wu, Aijun Shen, Peijun Wang

Magnetic Resonance Imaging · 2024

DOI: 10.1016/j.mri.2023.12.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance Imaging, 2024. Verfasst von Yun Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China; Institute of Medical Imaging Artificia…. Hauptthemen laut MEDLINE: Protons, Kidney Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the potential of amide proton transfer-weighted (APTw) MRI in identifying benign and malignant renal tumors and to evaluate whether APTw MRI can add diagnostic value to diffusion-weighted imaging (DWI). MATERIALS AND METHODS: Participants with renal tumor underwent preoperative multiparametric MRI, including APTw MRI and DWI. The APTw and apparent diffusion coefficient (ADC) of malignant tumors and benign tumors were calculated independently by two radiologists and compared. The value of the mean APTw and the mean ADC for differentiating malignant and benign tumors was evaluated by receiver operating characteristic analysis. RESULTS: In total, 65 participants (mean age, 59 years ±14; 41 men) were evaluated: 54 with malignant and 11 with benign renal tumors. Malignant renal tumors showed higher mean APTw values [2.03% (1.63) vs 1.00% (1.60); P 0.05). CONCLUSION: The APTw MRI has the potential use as an imaging biomarker for renal malignant and benign tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProtonsKidney NeoplasmsMaleHumansMiddle AgedAmidesDiffusion Magnetic Resonance ImagingMagnetic Resonance ImagingDiagnosis, DifferentialSensitivity and SpecificityRetrospective Studies

Stichwörter der Autor:innen

Amide proton transfer-weighted (APTw)Diffusion weighted imaging (DWI)Magnetic resonance imaging (MRI)Renal tumor

Substanzen

ProtonsAmides

Autor:innen und Institutionen

  • Department of Medical Imaging, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China; Institute of Medical Imaging Artificial Intelligence, Tongji University School of Medicine, Shanghai 200065,…
  • Philips Healthcare, Shanghai 200072, China.

Förderung

  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Xu, Y., Wan, Q., Ren, X., Jiang, Y., Wang, F., Yao, J., Wu, P., Shen, A., & Wang, P. (2024). Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging. Magnetic Resonance Imaging. https://doi.org/10.1016/j.mri.2023.12.002

Vancouver

Xu Y, Wan Q, Ren X, Jiang Y, Wang F, Yao J, et al. Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging. Magnetic Resonance Imaging. 2024. doi:10.1016/j.mri.2023.12.002

BibTeX
@article{Xu2024,
  author = {Xu, Yun and Wan, Qingxuan and Ren, Xihui and Jiang, Yutao and Wang, Fang and Yao, Jing and Wu, Peng and Shen, Aijun and Wang, Peijun},
  title = {Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging},
  journal = {Magnetic Resonance Imaging},
  year = {2024},
  doi = {10.1016/j.mri.2023.12.002}
}
Kostenlos starten →